Home       About             Help      

Select plot or tool >
Pheno measurements correlated to your selected measurements

Pearson correlation p value
must be p ≤


Download all
At least
strains
in common
are required
Include:
females and males
females only
males only

Order by


More info on correlations


Your selected measurement:
blood — hematology — cell counts — WBC — lymphocytes — count         CBC  
Peters4
LYMPH_M12   lymphocyte count (LYMP; units per volume x 103)   [n/µL]
31 strains   age 12mo
  Inbred
 

Download this list as a tab-delimited file
 
Correlated measurement from anywhere in MPD
(organized by category)
Sex Pearson
r
p value
on r
Spearman
rs
# strains
in
common
Click
for
scatterplot
Log-
improved
Pearson
behavior – balance and coordination
Crabbe3   ARR1_performance  
accelerating rotarod (ARR1) acquisition trial average over all trials (20 rpm/min)
female 0.94 p = 0.0004 0.52 8 Plot  
Crabbe3   ARR1_pre_20rpm  
accelerating rotarod (ARR1) day 1 latency to fall prior to ethanol treatment (20 rpm/min)
female 0.92 p = 0.0010 0.62 8 Plot  
Crabbe3   ARR1_pre_30rpm  
accelerating rotarod (ARR1) day 2 latency to fall prior to ethanol treatment (30 rpm/min)
female 0.88 p = 0.0037 0.61 8 Plot  
behavior – exploratory
Wahlsten1   dist_ave_EPM  
average distance traveled in 1 min
male 0.68 p = 0.0079 0.27 14 Plot  
behavior – locomotor activity
Wahlsten1   dist_EPM_min3  
distance traveled, elevated plus maze minute 3
male 0.72 p = 0.0040 0.47 14 Plot  
Wahlsten1   dist_EPM_min5  
distance traveled, elevated plus maze minute 5
male 0.69 p = 0.0067 0.33 14 Plot  
Evsikova1   horiz_daily  
ambulatory (horizontal) activity count, daily (1 count = 3 consecutive beam breaks) (age 6mo)
male 0.76 p = 0.0067 0.74 11 Plot 0.81
Wahlsten1   speed_ave_EPM  
speed when moving; average over 5 min
male 0.68 p = 0.0079 0.27 14 Plot  
Wahlsten1   dist_EPM_min4  
distance traveled, elevated plus maze minute 4
male 0.67 p = 0.0084 0.23 14 Plot  
Evsikova1   horiz_Dk  
ambulatory (horizontal) activity count, dark cycle (1 count = 3 consecutive beam breaks) (age 6mo)
male 0.74 p = 0.0096 0.72 11 Plot 0.80
behavior – visuospatial learning
Brown2   acq_lat_d1  
acquisition training mean latency to escape, day 1
female –0.92 p = 0.0002 –0.84 10 Plot -0.96
behavior – wildness
Wahlsten2   nbite  
number of tests with bites
female 0.86 p < 0.0001 0.74 14 Plot  
Wahlsten2   rrod  
wildness rating, mean during rotarod
female 0.82 p = 0.0004 0.66 14 Plot  
Wahlsten2   hold  
hold rating, overall mean
female 0.81 p = 0.0005 0.72 14 Plot  
Wahlsten2   nflee  
number of tests with escapes
female 0.74 p = 0.0023 0.57 14 Plot 0.77
Wahlsten2   wildness  
wildness rating, sum of capture and hold means
female 0.74 p = 0.0026 0.60 14 Plot  
Wahlsten2   nplacid  
number of placid tests (capture ratings + hold ratings)
female –0.68 p = 0.0073 –0.58 14 Plot  
blood – clinical chemistry – electrolytes
Yuan3   K_M06  
potassium (serum K) (age 6mo)
male –0.59 p = 0.0022 –0.61 24 Plot  
blood – hematology – cell counts – WBC
Peters4   WBC_M12  
white blood cell count (WBC; per volume x 103) (age 12mo)
female 0.97 p < 0.0001 0.96 30 Plot  
Peters4   WBC_M12  
white blood cell count (WBC; per volume x 103) (age 12mo)
male 0.92 p < 0.0001 0.93 30 Plot  
Peters4   WBC_M18  
white blood cell count (WBC; per volume x 103) (age 18mo)
male 0.79 p < 0.0001 0.75 29 Plot  
Peters4   WBC_M06  
white blood cell count (WBC; per volume x 103) (age 6mo)
male 0.76 p < 0.0001 0.74 30 Plot  
CGDpheno1   WBC  
white blood cell count (WBC; per volume x 103)
female 0.70 p < 0.0001 0.65 26 Plot  
Petkova1   WBC_M18  
white blood cell count (WBC; per volume x 103) (age 18mo)
male 0.70 p = 0.0001 0.60 24 Plot  
Peters4   WBC_M06  
white blood cell count (WBC; per volume x 103) (age 6mo)
female 0.60 p = 0.0004 0.73 30 Plot 0.64
Peters4   WBC_M18  
white blood cell count (WBC; per volume x 103) (age 18mo)
female 0.62 p = 0.0005 0.56 28 Plot  
Petkova1   WBC_M18  
white blood cell count (WBC; per volume x 103) (age 18mo)
female 0.61 p = 0.0006 0.69 28 Plot 0.73
Petkova1   WBC_M06  
white blood cell count (WBC; per volume x 103) (age 6mo)
female 0.56 p = 0.0014 0.58 30 Plot  
CGDpheno1   WBC  
white blood cell count (WBC; per volume x 103)
male 0.55 p = 0.0035 0.45 26 Plot  
Peters1   WBC  
white blood cell count (WBC; per volume x 103)
female 0.56 p = 0.0039 0.64 25 Plot  
blood – hematology – cell counts – WBC – basophils
Peters4   BASO_M18  
basophil count (BASO; units per volume x 103) (age 18mo)
male 0.72 p < 0.0001 0.60 29 Plot  
Peters4   BASO_M12  
basophil count (BASO; units per volume x 103) (age 12mo)
female 0.65 p < 0.0001 0.63 30 Plot  
Peters4   BASO_M12  
basophil count (BASO; units per volume x 103) (age 12mo)
male 0.62 p = 0.0002 0.57 30 Plot  
Peters4   BASO_M06  
basophil count (BASO; units per volume x 103) (age 6mo)
male 0.57 p = 0.0010 0.49 30 Plot  
Peters4   pctBASO_M24  
basophil differential (percent of total WBC) (age 24mo)
female 0.80 p = 0.0030 0.77 11 Plot  
Peters4   BASO_M06  
basophil count (BASO; units per volume x 103) (age 6mo)
female 0.48 p = 0.0077 0.55 30 Plot  
Peters4   BASO_M24  
basophil count (BASO; units per volume x 103) (age 24mo)
female 0.74 p = 0.0099 0.80 11 Plot  
blood – hematology – cell counts – WBC – lymphocytes
Peters4   LYMPH_M18  
lymphocyte count (LYMP; units per volume x 103) (age 18mo)
male 0.88 p < 0.0001 0.81 29 Plot  
Peters4   LYMPH_M06  
lymphocyte count (LYMP; units per volume x 103) (age 6mo)
male 0.81 p < 0.0001 0.77 30 Plot  
Peters4   pctLYMPH_M12  
lymphocyte differential (percent of total WBC) (age 12mo)
male 0.81 p < 0.0001 0.78 30 Plot  
Peters4   pctLYMPH_M18  
lymphocyte differential (percent of total WBC) (age 18mo)
male 0.73 p < 0.0001 0.75 29 Plot  
Peters4   LYMPH_M18  
lymphocyte count (LYMP; units per volume x 103) (age 18mo)
female 0.72 p < 0.0001 0.64 28 Plot  
Peters4   LYMPH_M06  
lymphocyte count (LYMP; units per volume x 103) (age 6mo)
female 0.65 p = 0.0001 0.76 30 Plot 0.69
Peters4   pctLYMPH_M12  
lymphocyte differential (percent of total WBC) (age 12mo)
female 0.64 p = 0.0002 0.63 30 Plot 0.67
Petkova1   LYM_M18  
lymphocytes (percent of viable WBC) (age 18mo)
male 0.62 p = 0.0013 0.61 24 Plot  
Peters4   LYMPH_M24  
lymphocyte count (LYMP; units per volume x 103) (age 24mo)
male 0.80 p = 0.0018 0.81 12 Plot 0.83
Peters4   pctLYMPH_M18  
lymphocyte differential (percent of total WBC) (age 18mo)
female 0.55 p = 0.0026 0.41 28 Plot  
Petkova1   LYM_M18  
lymphocytes (percent of viable WBC) (age 18mo)
female 0.54 p = 0.0027 0.51 28 Plot  
Peters4   pctLYMPH_M06  
lymphocyte differential (percent of total WBC) (age 6mo)
female 0.50 p = 0.0045 0.51 30 Plot 0.55
Peters1   LYM  
lymphocyte differential (percent of total WBC)
female 0.52 p = 0.0084 0.46 25 Plot  
blood – hematology – cell counts – WBC – misc
Peters4   LUC_M12  
large unstained cells count (LUC; units per volume x 103) (age 12mo)
female 0.81 p < 0.0001 0.74 30 Plot  
Peters4   LUC_M12  
large unstained cells count (LUC; units per volume x 103) (age 12mo)
male 0.81 p < 0.0001 0.83 30 Plot  
Peters4   LUC_M06  
large unstained cells count (LUC; units per volume x 103) (age 6mo)
male 0.65 p = 0.0001 0.67 30 Plot  
Peters4   LUC_M06  
large unstained cells count (LUC; units per volume x 103) (age 6mo)
female 0.65 p = 0.0001 0.70 30 Plot  
Peters4   LUC_M18  
large unstained cells count (LUC; units per volume x 103) (age 18mo)
male 0.64 p = 0.0002 0.67 29 Plot 0.67
Peters4   pctLUC_M12  
large unstained cell differential (percent of total WBC) (age 12mo)
male 0.63 p = 0.0002 0.57 30 Plot 0.70
Peters4   pctLUC_M06  
large unstained cell differential (percent of total WBC) (age 6mo)
female 0.58 p = 0.0007 0.46 30 Plot  
Peters1   LUC  
large unstained cell differential (percent of total WBC)
male 0.56 p = 0.0040 0.46 25 Plot  
Peters4   pctLUC_M06  
large unstained cell differential (percent of total WBC) (age 6mo)
male 0.49 p = 0.0058 0.57 30 Plot 0.53
blood – hematology – cell counts – WBC – monocytes
Peters4   pctMONO_M06  
monocyte differential (percent of total WBC) (age 6mo)
male –0.54 p = 0.0021 –0.62 30 Plot  
Peters4   pctMONO_M12  
monocyte differential (percent of total WBC) (age 12mo)
male –0.50 p = 0.0047 –0.59 30 Plot  
blood – hematology – cell counts – WBC – neutrophils
Peters4   pctNEUT_M12  
neutrophil differential (percent of total WBC) (age 12mo)
male –0.78 p < 0.0001 –0.73 30 Plot  
Peters4   pctNEUT_M18  
neutrophil differential (percent of total WBC) (age 18mo)
male –0.72 p < 0.0001 –0.74 29 Plot  
Petkova1   NEUT_M18  
neutrophils (percent of viable WBC) (age 18mo)
male –0.71 p = 0.0001 –0.70 24 Plot -0.76
Peters4   pctNEUT_M12  
neutrophil differential (percent of total WBC) (age 12mo)
female –0.62 p = 0.0002 –0.64 30 Plot -0.71
Petkova1   NEUT_M12  
neutrophils (percent of viable WBC) (age 12mo)
male –0.55 p = 0.0023 –0.62 28 Plot -0.59
Peters4   pctNEUT_M06  
neutrophil differential (percent of total WBC) (age 6mo)
female –0.53 p = 0.0025 –0.58 30 Plot -0.59
Peters4   pctNEUT_M18  
neutrophil differential (percent of total WBC) (age 18mo)
female –0.55 p = 0.0025 –0.45 28 Plot -0.65
Peters1   NEUT  
neutrophil differential (percent of total WBC)
female –0.58 p = 0.0026 –0.55 25 Plot  
CGDpheno1   pctNEUT  
neutrophil differential (percent of total WBC)
female –0.56 p = 0.0027 –0.55 26 Plot  
Petkova1   NEUT_M24  
neutrophils (percent of viable WBC) (age 24mo)
male –0.79 p = 0.0035 –0.77 11 Plot -0.82
Petkova1   NEUT_M18  
neutrophils (percent of viable WBC) (age 18mo)
female –0.53 p = 0.0040 –0.58 28 Plot -0.60
Petkova1   NEUT_M06  
neutrophils (percent of viable WBC) (age 6mo)
male –0.49 p = 0.0072 –0.55 29 Plot -0.60
blood – lipids – triglycerides
Albers1   TG_chow  
total triglycerides
male –0.81 p = 0.0080 –0.69 9 Plot  
blood – xenobiotics – drug and metabolite concentration
Rusyn2   DCV_glutathione24_tce  
S-(1,2-dichlorovinyl) glutathione (serum DCVG, x 10-3), t=24h (trichloroethylene )
male –0.92 p = 0.0005 –0.87 9 Plot -0.95
body weight size and growth – body weight
Rhodes1   BW_chg_wheel  
fold-change in body weight, with exercise wheel (6wks) (exercise )
male –0.86 p = 0.0063 –0.60 8 Plot  
brain – electroconvulsive threshold
Frankel1   E-PS-BH-TC  
median critical current (CC50) for psychomotor seizure, transcorneal stimulation (at BH)
male 0.93 p < 0.0001 0.84 10 Plot  
cardiovascular – ECG parameters
Maurer1   QRS_iso10  
interval between beginning and end of QRS complex (isoproterenol 10mg/kg 2wks)
male 0.66 p = 0.0057 0.56 16 Plot  
endocrine – adrenal
Deschepper1   adrenal_bi_adj  
adrenal weight (both), per gram of body weight
male 0.82 p = 0.0021 0.59 11 Plot  
Deschepper1   adrenal_L_adj  
adrenal (left) weight, per gram of body weight
male 0.79 p = 0.0042 0.50 11 Plot  
Deschepper1   adrenal_R_adj  
adrenal (right) weight, per gram of body weight
male 0.78 p = 0.0049 0.54 11 Plot  
immune system – cell counts – peripheral blood
Petkova1   B_cells_M12  
B cells (as percent of total lymphocytes) (age 12mo)
female 0.51 p = 0.0046 0.49 29 Plot 0.56
kidney – function
Rusyn5   peak_UAC_hfe  
urine alcohol concentration (UAC), daily peak (high-fat diet and ethanol 4wks)
male –0.74 p = 0.0094 –0.77 11 Plot -0.77
respiratory – airway resistance
Berndt1   airway_res  
airway resistance (naive, untreated, H2O pressure)
female –0.56 p = 0.0026 –0.60 27 Plot  
Berndt2   airway_res_mch3  
airway resistance (Rn) (H20 pressure) (methacholine 3mg/mL)
female –0.56 p = 0.0058 –0.60 23 Plot  
Berndt1   airway_res_mch3  
airway resistance (H2O pressure) (methacholine 3mg/mL)
female –0.50 p = 0.0083 –0.50 27 Plot  
 

86 rows

Reciprocals are included in the above list.

Correlations where Pearson r < 0.5 are not retained and will not appear in the above list.

All correlations available through MPD are mathematical correlations provided for exploratory use, and are not necessarily biologically significant. Additional forms of validation are required. Most correlations are based on strain mean data points which have varying degrees of quality, preciseness, and normality of distribution, and this is generally not taken into account in correlation strength metrics.




Hosted by:
  Contact us
About MPD
Also at JAX
  Units
Changelog
Downloads
  Citing
Funding
Terms of Use